nodes	percent_of_prediction	percent_of_DWPC	metapath
Teniposide—Etoposide—uterine cancer	0.291	1	CrCtD
Teniposide—Podofilox—Etoposide—uterine cancer	0.166	1	CrCrCtD
Teniposide—Topoisomerase Inhibitors—Etoposide—uterine cancer	0.147	0.43	CiPCiCtD
Teniposide—Topoisomerase Inhibitors—Epirubicin—uterine cancer	0.101	0.296	CiPCiCtD
Teniposide—Topoisomerase Inhibitors—Doxorubicin—uterine cancer	0.0938	0.274	CiPCiCtD
Teniposide—ABCC6—Dactinomycin—uterine cancer	0.035	0.245	CbGbCtD
Teniposide—ABCC6—Etoposide—uterine cancer	0.0198	0.138	CbGbCtD
Teniposide—TOP2A—Epirubicin—uterine cancer	0.0135	0.0946	CbGbCtD
Teniposide—ABCC6—Doxorubicin—uterine cancer	0.0135	0.0944	CbGbCtD
Teniposide—TOP2A—Etoposide—uterine cancer	0.0105	0.0737	CbGbCtD
Teniposide—TOP2A—Doxorubicin—uterine cancer	0.00718	0.0503	CbGbCtD
Teniposide—ABCG2—Dactinomycin—uterine cancer	0.00692	0.0484	CbGbCtD
Teniposide—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.00489	0.0343	CbGbCtD
Teniposide—CYP3A5—Progesterone—uterine cancer	0.00483	0.0338	CbGbCtD
Teniposide—ABCG2—Carboplatin—uterine cancer	0.00465	0.0325	CbGbCtD
Teniposide—ABCG2—Etoposide—uterine cancer	0.0039	0.0273	CbGbCtD
Teniposide—CYP2C19—Progesterone—uterine cancer	0.0039	0.0273	CbGbCtD
Teniposide—CYP2C9—Progesterone—uterine cancer	0.00324	0.0227	CbGbCtD
Teniposide—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.00284	0.0199	CbGbCtD
Teniposide—ABCG2—Doxorubicin—uterine cancer	0.00266	0.0186	CbGbCtD
Teniposide—CYP3A5—Etoposide—uterine cancer	0.00216	0.0151	CbGbCtD
Teniposide—CYP3A4—Progesterone—uterine cancer	0.00188	0.0132	CbGbCtD
Teniposide—CYP3A4—Etoposide—uterine cancer	0.000843	0.0059	CbGbCtD
Teniposide—NCOA1—myometrium—uterine cancer	0.000807	0.0605	CbGeAlD
Teniposide—NCOA1—uterine cervix—uterine cancer	0.000628	0.0471	CbGeAlD
Teniposide—NCOA1—decidua—uterine cancer	0.000598	0.0448	CbGeAlD
Teniposide—CYP3A4—Doxorubicin—uterine cancer	0.000575	0.00403	CbGbCtD
Teniposide—NCOA1—endometrium—uterine cancer	0.000568	0.0426	CbGeAlD
Teniposide—NCOA3—myometrium—uterine cancer	0.000562	0.0421	CbGeAlD
Teniposide—NCOA1—mammalian vulva—uterine cancer	0.00055	0.0412	CbGeAlD
Teniposide—NCOA1—uterus—uterine cancer	0.000524	0.0392	CbGeAlD
Teniposide—NCOA3—uterine cervix—uterine cancer	0.000438	0.0328	CbGeAlD
Teniposide—NCOA1—female gonad—uterine cancer	0.000428	0.0321	CbGeAlD
Teniposide—NCOA1—vagina—uterine cancer	0.000426	0.0319	CbGeAlD
Teniposide—NCOA3—smooth muscle tissue—uterine cancer	0.000425	0.0319	CbGeAlD
Teniposide—NCOA3—decidua—uterine cancer	0.000417	0.0312	CbGeAlD
Teniposide—NCOA3—renal system—uterine cancer	0.000409	0.0307	CbGeAlD
Teniposide—NCOA3—endometrium—uterine cancer	0.000396	0.0297	CbGeAlD
Teniposide—NCOA3—mammalian vulva—uterine cancer	0.000383	0.0287	CbGeAlD
Teniposide—NCOA3—uterus—uterine cancer	0.000365	0.0273	CbGeAlD
Teniposide—ABCC6—renal system—uterine cancer	0.00036	0.027	CbGeAlD
Teniposide—TOP2A—myometrium—uterine cancer	0.00033	0.0247	CbGeAlD
Teniposide—NCOA3—female reproductive system—uterine cancer	0.000328	0.0246	CbGeAlD
Teniposide—NCOA3—female gonad—uterine cancer	0.000298	0.0224	CbGeAlD
Teniposide—NCOA3—vagina—uterine cancer	0.000297	0.0222	CbGeAlD
Teniposide—NCOA1—lymph node—uterine cancer	0.000275	0.0206	CbGeAlD
Teniposide—Myelosuppression—Etoposide—uterine cancer	0.000264	0.0111	CcSEcCtD
Teniposide—Leukaemia—Epirubicin—uterine cancer	0.000258	0.0108	CcSEcCtD
Teniposide—TOP2A—uterine cervix—uterine cancer	0.000257	0.0192	CbGeAlD
Teniposide—ABCC6—Podofilox—Etoposide—uterine cancer	0.000251	0.287	CbGdCrCtD
Teniposide—TOP2A—decidua—uterine cancer	0.000245	0.0183	CbGeAlD
Teniposide—Acute leukaemia—Epirubicin—uterine cancer	0.000243	0.0102	CcSEcCtD
Teniposide—Leukaemia—Doxorubicin—uterine cancer	0.000238	0.00999	CcSEcCtD
Teniposide—TOP2A—endometrium—uterine cancer	0.000232	0.0174	CbGeAlD
Teniposide—Acute leukaemia—Doxorubicin—uterine cancer	0.000225	0.00942	CcSEcCtD
Teniposide—TOP2A—mammalian vulva—uterine cancer	0.000225	0.0168	CbGeAlD
Teniposide—Mucosal inflammation—Etoposide—uterine cancer	0.000224	0.00937	CcSEcCtD
Teniposide—Neoplasm—Progesterone—uterine cancer	0.000219	0.00917	CcSEcCtD
Teniposide—Nephropathy toxic—Etoposide—uterine cancer	0.000216	0.00904	CcSEcCtD
Teniposide—TOP2A—uterus—uterine cancer	0.000214	0.016	CbGeAlD
Teniposide—Hepatic function abnormal—Progesterone—uterine cancer	0.000201	0.00843	CcSEcCtD
Teniposide—Neoplasm—Medroxyprogesterone Acetate—uterine cancer	0.000198	0.00831	CcSEcCtD
Teniposide—Extravasation—Dactinomycin—uterine cancer	0.000196	0.00822	CcSEcCtD
Teniposide—NCOA3—lymph node—uterine cancer	0.000192	0.0144	CbGeAlD
Teniposide—Sepsis—Medroxyprogesterone Acetate—uterine cancer	0.00019	0.00798	CcSEcCtD
Teniposide—Hepatic function abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000182	0.00763	CcSEcCtD
Teniposide—Neurotoxicity—Epirubicin—uterine cancer	0.000179	0.0075	CcSEcCtD
Teniposide—Haemolytic anaemia—Medroxyprogesterone Acetate—uterine cancer	0.000176	0.00739	CcSEcCtD
Teniposide—TOP2A—female gonad—uterine cancer	0.000175	0.0131	CbGeAlD
Teniposide—Cyanosis—Etoposide—uterine cancer	0.000175	0.00733	CcSEcCtD
Teniposide—TOP2A—vagina—uterine cancer	0.000174	0.013	CbGeAlD
Teniposide—NCOA3—Idarubicin—Epirubicin—uterine cancer	0.000173	0.198	CbGdCrCtD
Teniposide—Neurotoxicity—Doxorubicin—uterine cancer	0.000166	0.00694	CcSEcCtD
Teniposide—ABCG2—myometrium—uterine cancer	0.000164	0.0123	CbGeAlD
Teniposide—Infection—Carboplatin—uterine cancer	0.000163	0.00684	CcSEcCtD
Teniposide—Liver function test abnormal—Progesterone—uterine cancer	0.000162	0.0068	CcSEcCtD
Teniposide—NCOA3—Idarubicin—Doxorubicin—uterine cancer	0.00016	0.183	CbGdCrCtD
Teniposide—Sepsis—Dactinomycin—uterine cancer	0.000148	0.00622	CcSEcCtD
Teniposide—Myelosuppression—Epirubicin—uterine cancer	0.000148	0.0062	CcSEcCtD
Teniposide—Phlebitis—Dactinomycin—uterine cancer	0.000144	0.00604	CcSEcCtD
Teniposide—Extravasation—Etoposide—uterine cancer	0.000142	0.00595	CcSEcCtD
Teniposide—Myelosuppression—Doxorubicin—uterine cancer	0.000137	0.00574	CcSEcCtD
Teniposide—Bronchospasm—Medroxyprogesterone Acetate—uterine cancer	0.000135	0.00567	CcSEcCtD
Teniposide—Neuropathy peripheral—Progesterone—uterine cancer	0.000133	0.00556	CcSEcCtD
Teniposide—Body temperature increased—Carboplatin—uterine cancer	0.00013	0.00545	CcSEcCtD
Teniposide—ABCG2—uterine cervix—uterine cancer	0.000128	0.00959	CbGeAlD
Teniposide—Mucosal inflammation—Epirubicin—uterine cancer	0.000125	0.00525	CcSEcCtD
Teniposide—Haemoglobin—Progesterone—uterine cancer	0.000122	0.00512	CcSEcCtD
Teniposide—ABCG2—decidua—uterine cancer	0.000122	0.00914	CbGeAlD
Teniposide—Haemorrhage—Progesterone—uterine cancer	0.000122	0.00509	CcSEcCtD
Teniposide—Neuropathy peripheral—Medroxyprogesterone Acetate—uterine cancer	0.00012	0.00504	CcSEcCtD
Teniposide—Stomatitis—Medroxyprogesterone Acetate—uterine cancer	0.00012	0.00501	CcSEcCtD
Teniposide—CYP3A5—uterine cervix—uterine cancer	0.000119	0.0089	CbGeAlD
Teniposide—Sweating—Medroxyprogesterone Acetate—uterine cancer	0.000118	0.00493	CcSEcCtD
Teniposide—Neuropathy—Etoposide—uterine cancer	0.000116	0.00487	CcSEcCtD
Teniposide—Mucosal inflammation—Doxorubicin—uterine cancer	0.000116	0.00486	CcSEcCtD
Teniposide—ABCG2—endometrium—uterine cancer	0.000116	0.00867	CbGeAlD
Teniposide—Liver function test abnormal—Dactinomycin—uterine cancer	0.000115	0.0048	CcSEcCtD
Teniposide—TOP2A—lymph node—uterine cancer	0.000113	0.00843	CbGeAlD
Teniposide—ABCG2—mammalian vulva—uterine cancer	0.000112	0.00839	CbGeAlD
Teniposide—CYP3A5—renal system—uterine cancer	0.000111	0.00833	CbGeAlD
Teniposide—Haemoglobin—Medroxyprogesterone Acetate—uterine cancer	0.000111	0.00464	CcSEcCtD
Teniposide—Haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00011	0.00462	CcSEcCtD
Teniposide—Sepsis—Etoposide—uterine cancer	0.000107	0.0045	CcSEcCtD
Teniposide—Alopecia—Progesterone—uterine cancer	0.000107	0.0045	CcSEcCtD
Teniposide—ABCG2—uterus—uterine cancer	0.000107	0.00799	CbGeAlD
Teniposide—Phlebitis—Etoposide—uterine cancer	0.000104	0.00437	CcSEcCtD
Teniposide—Bone marrow depression—Epirubicin—uterine cancer	0.000103	0.00431	CcSEcCtD
Teniposide—CYP2C19—vagina—uterine cancer	0.000102	0.00766	CbGeAlD
Teniposide—Pancytopenia—Dactinomycin—uterine cancer	0.000102	0.00427	CcSEcCtD
Teniposide—Neutropenia—Dactinomycin—uterine cancer	0.0001	0.00421	CcSEcCtD
Teniposide—Chills—Medroxyprogesterone Acetate—uterine cancer	9.88e-05	0.00414	CcSEcCtD
Teniposide—Anaemia—Progesterone—uterine cancer	9.78e-05	0.0041	CcSEcCtD
Teniposide—Alopecia—Medroxyprogesterone Acetate—uterine cancer	9.73e-05	0.00408	CcSEcCtD
Teniposide—Bone marrow depression—Doxorubicin—uterine cancer	9.51e-05	0.00399	CcSEcCtD
Teniposide—Stomatitis—Dactinomycin—uterine cancer	9.33e-05	0.00391	CcSEcCtD
Teniposide—Hypertension—Progesterone—uterine cancer	9.14e-05	0.00383	CcSEcCtD
Teniposide—Chest pain—Progesterone—uterine cancer	9.01e-05	0.00378	CcSEcCtD
Teniposide—Anaemia—Medroxyprogesterone Acetate—uterine cancer	8.86e-05	0.00371	CcSEcCtD
Teniposide—Agitation—Medroxyprogesterone Acetate—uterine cancer	8.81e-05	0.00369	CcSEcCtD
Teniposide—CYP2C9—female reproductive system—uterine cancer	8.76e-05	0.00656	CbGeAlD
Teniposide—ABCG2—female gonad—uterine cancer	8.73e-05	0.00654	CbGeAlD
Teniposide—Confusional state—Progesterone—uterine cancer	8.71e-05	0.00365	CcSEcCtD
Teniposide—ABCG2—vagina—uterine cancer	8.67e-05	0.0065	CbGeAlD
Teniposide—Oedema—Progesterone—uterine cancer	8.64e-05	0.00362	CcSEcCtD
Teniposide—Infection—Progesterone—uterine cancer	8.58e-05	0.0036	CcSEcCtD
Teniposide—Tachycardia—Progesterone—uterine cancer	8.43e-05	0.00353	CcSEcCtD
Teniposide—Hyperhidrosis—Progesterone—uterine cancer	8.35e-05	0.0035	CcSEcCtD
Teniposide—CYP3A4—renal system—uterine cancer	8.34e-05	0.00625	CbGeAlD
Teniposide—Anorexia—Progesterone—uterine cancer	8.23e-05	0.00345	CcSEcCtD
Teniposide—Chest pain—Medroxyprogesterone Acetate—uterine cancer	8.16e-05	0.00342	CcSEcCtD
Teniposide—CYP3A5—female gonad—uterine cancer	8.1e-05	0.00607	CbGeAlD
Teniposide—Hypotension—Progesterone—uterine cancer	8.07e-05	0.00338	CcSEcCtD
Teniposide—CYP3A5—vagina—uterine cancer	8.05e-05	0.00603	CbGeAlD
Teniposide—Flushing—Dactinomycin—uterine cancer	7.97e-05	0.00334	CcSEcCtD
Teniposide—Extravasation—Epirubicin—uterine cancer	7.96e-05	0.00333	CcSEcCtD
Teniposide—Confusional state—Medroxyprogesterone Acetate—uterine cancer	7.89e-05	0.00331	CcSEcCtD
Teniposide—Oedema—Medroxyprogesterone Acetate—uterine cancer	7.83e-05	0.00328	CcSEcCtD
Teniposide—Infection—Medroxyprogesterone Acetate—uterine cancer	7.77e-05	0.00326	CcSEcCtD
Teniposide—Chills—Dactinomycin—uterine cancer	7.71e-05	0.00323	CcSEcCtD
Teniposide—Dyspnoea—Progesterone—uterine cancer	7.7e-05	0.00323	CcSEcCtD
Teniposide—Thrombocytopenia—Medroxyprogesterone Acetate—uterine cancer	7.66e-05	0.00321	CcSEcCtD
Teniposide—Bronchospasm—Etoposide—uterine cancer	7.64e-05	0.0032	CcSEcCtD
Teniposide—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	7.64e-05	0.0032	CcSEcCtD
Teniposide—Alopecia—Dactinomycin—uterine cancer	7.59e-05	0.00318	CcSEcCtD
Teniposide—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	7.56e-05	0.00317	CcSEcCtD
Teniposide—Decreased appetite—Progesterone—uterine cancer	7.51e-05	0.00315	CcSEcCtD
Teniposide—Anorexia—Medroxyprogesterone Acetate—uterine cancer	7.46e-05	0.00313	CcSEcCtD
Teniposide—Pancytopenia—Etoposide—uterine cancer	7.38e-05	0.00309	CcSEcCtD
Teniposide—Extravasation—Doxorubicin—uterine cancer	7.36e-05	0.00308	CcSEcCtD
Teniposide—Hypotension—Medroxyprogesterone Acetate—uterine cancer	7.31e-05	0.00306	CcSEcCtD
Teniposide—Neutropenia—Etoposide—uterine cancer	7.26e-05	0.00304	CcSEcCtD
Teniposide—Feeling abnormal—Progesterone—uterine cancer	7.12e-05	0.00298	CcSEcCtD
Teniposide—Gastrointestinal pain—Progesterone—uterine cancer	7.06e-05	0.00296	CcSEcCtD
Teniposide—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	6.98e-05	0.00292	CcSEcCtD
Teniposide—Anaemia—Dactinomycin—uterine cancer	6.91e-05	0.0029	CcSEcCtD
Teniposide—Urticaria—Progesterone—uterine cancer	6.86e-05	0.00288	CcSEcCtD
Teniposide—Body temperature increased—Progesterone—uterine cancer	6.83e-05	0.00286	CcSEcCtD
Teniposide—Abdominal pain—Progesterone—uterine cancer	6.83e-05	0.00286	CcSEcCtD
Teniposide—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	6.8e-05	0.00285	CcSEcCtD
Teniposide—Neuropathy peripheral—Etoposide—uterine cancer	6.79e-05	0.00285	CcSEcCtD
Teniposide—Stomatitis—Etoposide—uterine cancer	6.75e-05	0.00283	CcSEcCtD
Teniposide—Leukopenia—Dactinomycin—uterine cancer	6.69e-05	0.00281	CcSEcCtD
Teniposide—CYP3A4—female reproductive system—uterine cancer	6.68e-05	0.005	CbGeAlD
Teniposide—Neuropathy—Epirubicin—uterine cancer	6.52e-05	0.00273	CcSEcCtD
Teniposide—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	6.45e-05	0.0027	CcSEcCtD
Teniposide—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	6.4e-05	0.00268	CcSEcCtD
Teniposide—Hypersensitivity—Progesterone—uterine cancer	6.36e-05	0.00267	CcSEcCtD
Teniposide—Neoplasm—Epirubicin—uterine cancer	6.28e-05	0.00263	CcSEcCtD
Teniposide—Urticaria—Medroxyprogesterone Acetate—uterine cancer	6.22e-05	0.00261	CcSEcCtD
Teniposide—Asthenia—Progesterone—uterine cancer	6.2e-05	0.0026	CcSEcCtD
Teniposide—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	6.19e-05	0.00259	CcSEcCtD
Teniposide—Body temperature increased—Medroxyprogesterone Acetate—uterine cancer	6.19e-05	0.00259	CcSEcCtD
Teniposide—Pruritus—Progesterone—uterine cancer	6.11e-05	0.00256	CcSEcCtD
Teniposide—Oedema—Dactinomycin—uterine cancer	6.1e-05	0.00256	CcSEcCtD
Teniposide—Infection—Dactinomycin—uterine cancer	6.06e-05	0.00254	CcSEcCtD
Teniposide—Neuropathy—Doxorubicin—uterine cancer	6.03e-05	0.00253	CcSEcCtD
Teniposide—Sepsis—Epirubicin—uterine cancer	6.02e-05	0.00252	CcSEcCtD
Teniposide—Thrombocytopenia—Dactinomycin—uterine cancer	5.98e-05	0.0025	CcSEcCtD
Teniposide—Diarrhoea—Progesterone—uterine cancer	5.91e-05	0.00248	CcSEcCtD
Teniposide—Phlebitis—Epirubicin—uterine cancer	5.85e-05	0.00245	CcSEcCtD
Teniposide—Anorexia—Dactinomycin—uterine cancer	5.82e-05	0.00244	CcSEcCtD
Teniposide—Neoplasm—Doxorubicin—uterine cancer	5.81e-05	0.00243	CcSEcCtD
Teniposide—Flushing—Etoposide—uterine cancer	5.77e-05	0.00242	CcSEcCtD
Teniposide—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	5.77e-05	0.00242	CcSEcCtD
Teniposide—Hepatic function abnormal—Epirubicin—uterine cancer	5.76e-05	0.00242	CcSEcCtD
Teniposide—Asthenia—Medroxyprogesterone Acetate—uterine cancer	5.61e-05	0.00235	CcSEcCtD
Teniposide—ABCG2—lymph node—uterine cancer	5.61e-05	0.0042	CbGeAlD
Teniposide—Chills—Etoposide—uterine cancer	5.58e-05	0.00234	CcSEcCtD
Teniposide—Sepsis—Doxorubicin—uterine cancer	5.57e-05	0.00234	CcSEcCtD
Teniposide—Pruritus—Medroxyprogesterone Acetate—uterine cancer	5.54e-05	0.00232	CcSEcCtD
Teniposide—Alopecia—Etoposide—uterine cancer	5.49e-05	0.0023	CcSEcCtD
Teniposide—Vomiting—Progesterone—uterine cancer	5.49e-05	0.0023	CcSEcCtD
Teniposide—Rash—Progesterone—uterine cancer	5.44e-05	0.00228	CcSEcCtD
Teniposide—Dermatitis—Progesterone—uterine cancer	5.44e-05	0.00228	CcSEcCtD
Teniposide—Phlebitis—Doxorubicin—uterine cancer	5.41e-05	0.00227	CcSEcCtD
Teniposide—Headache—Progesterone—uterine cancer	5.41e-05	0.00227	CcSEcCtD
Teniposide—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	5.35e-05	0.00224	CcSEcCtD
Teniposide—Hepatic function abnormal—Doxorubicin—uterine cancer	5.33e-05	0.00224	CcSEcCtD
Teniposide—Decreased appetite—Dactinomycin—uterine cancer	5.31e-05	0.00222	CcSEcCtD
Teniposide—Nausea—Progesterone—uterine cancer	5.13e-05	0.00215	CcSEcCtD
Teniposide—Feeling abnormal—Dactinomycin—uterine cancer	5.03e-05	0.00211	CcSEcCtD
Teniposide—Anaemia—Etoposide—uterine cancer	5e-05	0.0021	CcSEcCtD
Teniposide—Gastrointestinal pain—Dactinomycin—uterine cancer	4.99e-05	0.00209	CcSEcCtD
Teniposide—Vomiting—Medroxyprogesterone Acetate—uterine cancer	4.98e-05	0.00209	CcSEcCtD
Teniposide—Rash—Medroxyprogesterone Acetate—uterine cancer	4.93e-05	0.00207	CcSEcCtD
Teniposide—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	4.93e-05	0.00207	CcSEcCtD
Teniposide—Headache—Medroxyprogesterone Acetate—uterine cancer	4.9e-05	0.00205	CcSEcCtD
Teniposide—Leukopenia—Etoposide—uterine cancer	4.85e-05	0.00203	CcSEcCtD
Teniposide—Abdominal pain—Dactinomycin—uterine cancer	4.83e-05	0.00202	CcSEcCtD
Teniposide—Body temperature increased—Dactinomycin—uterine cancer	4.83e-05	0.00202	CcSEcCtD
Teniposide—Hypertension—Etoposide—uterine cancer	4.67e-05	0.00196	CcSEcCtD
Teniposide—Liver function test abnormal—Epirubicin—uterine cancer	4.65e-05	0.00195	CcSEcCtD
Teniposide—Nausea—Medroxyprogesterone Acetate—uterine cancer	4.65e-05	0.00195	CcSEcCtD
Teniposide—Chest pain—Etoposide—uterine cancer	4.61e-05	0.00193	CcSEcCtD
Teniposide—TOP2A—Podofilox—Etoposide—uterine cancer	4.54e-05	0.0521	CbGdCrCtD
Teniposide—Hypersensitivity—Dactinomycin—uterine cancer	4.5e-05	0.00188	CcSEcCtD
Teniposide—Confusional state—Etoposide—uterine cancer	4.45e-05	0.00187	CcSEcCtD
Teniposide—Infection—Etoposide—uterine cancer	4.39e-05	0.00184	CcSEcCtD
Teniposide—Asthenia—Dactinomycin—uterine cancer	4.38e-05	0.00184	CcSEcCtD
Teniposide—Thrombocytopenia—Etoposide—uterine cancer	4.33e-05	0.00181	CcSEcCtD
Teniposide—Tachycardia—Etoposide—uterine cancer	4.31e-05	0.00181	CcSEcCtD
Teniposide—Liver function test abnormal—Doxorubicin—uterine cancer	4.3e-05	0.0018	CcSEcCtD
Teniposide—Hyperhidrosis—Etoposide—uterine cancer	4.27e-05	0.00179	CcSEcCtD
Teniposide—Anorexia—Etoposide—uterine cancer	4.21e-05	0.00176	CcSEcCtD
Teniposide—Diarrhoea—Dactinomycin—uterine cancer	4.18e-05	0.00175	CcSEcCtD
Teniposide—Pancytopenia—Epirubicin—uterine cancer	4.14e-05	0.00173	CcSEcCtD
Teniposide—Hypotension—Etoposide—uterine cancer	4.13e-05	0.00173	CcSEcCtD
Teniposide—Neutropenia—Epirubicin—uterine cancer	4.07e-05	0.00171	CcSEcCtD
Teniposide—Dyspnoea—Etoposide—uterine cancer	3.94e-05	0.00165	CcSEcCtD
Teniposide—Vomiting—Dactinomycin—uterine cancer	3.88e-05	0.00163	CcSEcCtD
Teniposide—Rash—Dactinomycin—uterine cancer	3.85e-05	0.00161	CcSEcCtD
Teniposide—Decreased appetite—Etoposide—uterine cancer	3.84e-05	0.00161	CcSEcCtD
Teniposide—Pancytopenia—Doxorubicin—uterine cancer	3.83e-05	0.0016	CcSEcCtD
Teniposide—Neuropathy peripheral—Epirubicin—uterine cancer	3.81e-05	0.00159	CcSEcCtD
Teniposide—Stomatitis—Epirubicin—uterine cancer	3.78e-05	0.00159	CcSEcCtD
Teniposide—Neutropenia—Doxorubicin—uterine cancer	3.77e-05	0.00158	CcSEcCtD
Teniposide—Sweating—Epirubicin—uterine cancer	3.72e-05	0.00156	CcSEcCtD
Teniposide—TOP2A—Methyltestosterone—Medroxyprogesterone Acetate—uterine cancer	3.71e-05	0.0425	CbGdCrCtD
Teniposide—Feeling abnormal—Etoposide—uterine cancer	3.64e-05	0.00153	CcSEcCtD
Teniposide—Nausea—Dactinomycin—uterine cancer	3.63e-05	0.00152	CcSEcCtD
Teniposide—Gastrointestinal pain—Etoposide—uterine cancer	3.61e-05	0.00151	CcSEcCtD
Teniposide—Neuropathy peripheral—Doxorubicin—uterine cancer	3.52e-05	0.00148	CcSEcCtD
Teniposide—Urticaria—Etoposide—uterine cancer	3.51e-05	0.00147	CcSEcCtD
Teniposide—Haemoglobin—Epirubicin—uterine cancer	3.5e-05	0.00147	CcSEcCtD
Teniposide—Stomatitis—Doxorubicin—uterine cancer	3.5e-05	0.00147	CcSEcCtD
Teniposide—Abdominal pain—Etoposide—uterine cancer	3.49e-05	0.00146	CcSEcCtD
Teniposide—Body temperature increased—Etoposide—uterine cancer	3.49e-05	0.00146	CcSEcCtD
Teniposide—Haemorrhage—Epirubicin—uterine cancer	3.49e-05	0.00146	CcSEcCtD
Teniposide—Sweating—Doxorubicin—uterine cancer	3.44e-05	0.00144	CcSEcCtD
Teniposide—Hypersensitivity—Etoposide—uterine cancer	3.25e-05	0.00136	CcSEcCtD
Teniposide—Haemoglobin—Doxorubicin—uterine cancer	3.24e-05	0.00136	CcSEcCtD
Teniposide—Flushing—Epirubicin—uterine cancer	3.23e-05	0.00136	CcSEcCtD
Teniposide—TOP2A—Methyltestosterone—Progesterone—uterine cancer	3.23e-05	0.037	CbGdCrCtD
Teniposide—Haemorrhage—Doxorubicin—uterine cancer	3.22e-05	0.00135	CcSEcCtD
Teniposide—Asthenia—Etoposide—uterine cancer	3.17e-05	0.00133	CcSEcCtD
Teniposide—Chills—Epirubicin—uterine cancer	3.13e-05	0.00131	CcSEcCtD
Teniposide—Pruritus—Etoposide—uterine cancer	3.13e-05	0.00131	CcSEcCtD
Teniposide—Arrhythmia—Epirubicin—uterine cancer	3.11e-05	0.0013	CcSEcCtD
Teniposide—Alopecia—Epirubicin—uterine cancer	3.08e-05	0.00129	CcSEcCtD
Teniposide—Diarrhoea—Etoposide—uterine cancer	3.02e-05	0.00127	CcSEcCtD
Teniposide—Flushing—Doxorubicin—uterine cancer	2.99e-05	0.00125	CcSEcCtD
Teniposide—Chills—Doxorubicin—uterine cancer	2.89e-05	0.00121	CcSEcCtD
Teniposide—Arrhythmia—Doxorubicin—uterine cancer	2.88e-05	0.00121	CcSEcCtD
Teniposide—Alopecia—Doxorubicin—uterine cancer	2.85e-05	0.00119	CcSEcCtD
Teniposide—Vomiting—Etoposide—uterine cancer	2.81e-05	0.00118	CcSEcCtD
Teniposide—Anaemia—Epirubicin—uterine cancer	2.8e-05	0.00118	CcSEcCtD
Teniposide—Agitation—Epirubicin—uterine cancer	2.79e-05	0.00117	CcSEcCtD
Teniposide—Rash—Etoposide—uterine cancer	2.79e-05	0.00117	CcSEcCtD
Teniposide—Dermatitis—Etoposide—uterine cancer	2.78e-05	0.00117	CcSEcCtD
Teniposide—Headache—Etoposide—uterine cancer	2.77e-05	0.00116	CcSEcCtD
Teniposide—Leukopenia—Epirubicin—uterine cancer	2.72e-05	0.00114	CcSEcCtD
Teniposide—Nausea—Etoposide—uterine cancer	2.62e-05	0.0011	CcSEcCtD
Teniposide—Hypertension—Epirubicin—uterine cancer	2.62e-05	0.0011	CcSEcCtD
Teniposide—Anaemia—Doxorubicin—uterine cancer	2.59e-05	0.00109	CcSEcCtD
Teniposide—Chest pain—Epirubicin—uterine cancer	2.58e-05	0.00108	CcSEcCtD
Teniposide—Agitation—Doxorubicin—uterine cancer	2.58e-05	0.00108	CcSEcCtD
Teniposide—Leukopenia—Doxorubicin—uterine cancer	2.51e-05	0.00105	CcSEcCtD
Teniposide—Confusional state—Epirubicin—uterine cancer	2.5e-05	0.00105	CcSEcCtD
Teniposide—Oedema—Epirubicin—uterine cancer	2.48e-05	0.00104	CcSEcCtD
Teniposide—Infection—Epirubicin—uterine cancer	2.46e-05	0.00103	CcSEcCtD
Teniposide—Thrombocytopenia—Epirubicin—uterine cancer	2.42e-05	0.00102	CcSEcCtD
Teniposide—Hypertension—Doxorubicin—uterine cancer	2.42e-05	0.00102	CcSEcCtD
Teniposide—Tachycardia—Epirubicin—uterine cancer	2.42e-05	0.00101	CcSEcCtD
Teniposide—Hyperhidrosis—Epirubicin—uterine cancer	2.39e-05	0.001	CcSEcCtD
Teniposide—Chest pain—Doxorubicin—uterine cancer	2.39e-05	0.001	CcSEcCtD
Teniposide—TOP2A—Daunorubicin—Epirubicin—uterine cancer	2.37e-05	0.0272	CbGdCrCtD
Teniposide—TOP2A—Doxorubicin—Epirubicin—uterine cancer	2.37e-05	0.0272	CbGdCrCtD
Teniposide—TOP2A—Idarubicin—Epirubicin—uterine cancer	2.37e-05	0.0272	CbGdCrCtD
Teniposide—Anorexia—Epirubicin—uterine cancer	2.36e-05	0.000989	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—TP53—uterine cancer	2.32e-05	0.00119	CbGpPWpGaD
Teniposide—Hypotension—Epirubicin—uterine cancer	2.31e-05	0.00097	CcSEcCtD
Teniposide—Confusional state—Doxorubicin—uterine cancer	2.31e-05	0.000968	CcSEcCtD
Teniposide—CYP3A5—Metapathway biotransformation—AKR1C1—uterine cancer	2.3e-05	0.00118	CbGpPWpGaD
Teniposide—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	2.29e-05	0.00117	CbGpPWpGaD
Teniposide—Oedema—Doxorubicin—uterine cancer	2.29e-05	0.00096	CcSEcCtD
Teniposide—TOP2A—Cell Cycle—POLD1—uterine cancer	2.28e-05	0.00117	CbGpPWpGaD
Teniposide—Infection—Doxorubicin—uterine cancer	2.28e-05	0.000954	CcSEcCtD
Teniposide—NCOA1—Generic Transcription Pathway—SMAD3—uterine cancer	2.27e-05	0.00116	CbGpPWpGaD
Teniposide—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	2.26e-05	0.00116	CbGpPWpGaD
Teniposide—Thrombocytopenia—Doxorubicin—uterine cancer	2.24e-05	0.00094	CcSEcCtD
Teniposide—Tachycardia—Doxorubicin—uterine cancer	2.24e-05	0.000937	CcSEcCtD
Teniposide—NCOA3—Metabolism—POLD1—uterine cancer	2.23e-05	0.00114	CbGpPWpGaD
Teniposide—Hyperhidrosis—Doxorubicin—uterine cancer	2.21e-05	0.000928	CcSEcCtD
Teniposide—CYP2C9—Metapathway biotransformation—AKR1B1—uterine cancer	2.21e-05	0.00113	CbGpPWpGaD
Teniposide—Dyspnoea—Epirubicin—uterine cancer	2.21e-05	0.000925	CcSEcCtD
Teniposide—TOP2A—Idarubicin—Doxorubicin—uterine cancer	2.19e-05	0.0251	CbGdCrCtD
Teniposide—TOP2A—Epirubicin—Doxorubicin—uterine cancer	2.19e-05	0.0251	CbGdCrCtD
Teniposide—TOP2A—Daunorubicin—Doxorubicin—uterine cancer	2.19e-05	0.0251	CbGdCrCtD
Teniposide—Anorexia—Doxorubicin—uterine cancer	2.18e-05	0.000915	CcSEcCtD
Teniposide—Decreased appetite—Epirubicin—uterine cancer	2.15e-05	0.000902	CcSEcCtD
Teniposide—Hypotension—Doxorubicin—uterine cancer	2.14e-05	0.000897	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—SMAD3—uterine cancer	2.13e-05	0.00109	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—RRM2—uterine cancer	2.12e-05	0.00109	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—MET—uterine cancer	2.11e-05	0.00108	CbGpPWpGaD
Teniposide—TOP2A—Norethindrone—Progesterone—uterine cancer	2.11e-05	0.0241	CbGdCrCtD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—HRAS—uterine cancer	2.1e-05	0.00107	CbGpPWpGaD
Teniposide—ABCG2—Fluoropyrimidine Activity—TP53—uterine cancer	2.09e-05	0.00107	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—AKR1C1—uterine cancer	2.09e-05	0.00107	CbGpPWpGaD
Teniposide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	2.06e-05	0.00105	CbGpPWpGaD
Teniposide—Dyspnoea—Doxorubicin—uterine cancer	2.04e-05	0.000856	CcSEcCtD
Teniposide—Feeling abnormal—Epirubicin—uterine cancer	2.04e-05	0.000855	CcSEcCtD
Teniposide—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	2.04e-05	0.00104	CbGpPWpGaD
Teniposide—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	2.03e-05	0.00104	CbGpPWpGaD
Teniposide—Gastrointestinal pain—Epirubicin—uterine cancer	2.02e-05	0.000849	CcSEcCtD
Teniposide—CYP3A5—Metapathway biotransformation—GPX3—uterine cancer	2.02e-05	0.00104	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CDKN2A—uterine cancer	2e-05	0.00102	CbGpPWpGaD
Teniposide—Decreased appetite—Doxorubicin—uterine cancer	1.99e-05	0.000835	CcSEcCtD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—ESR1—uterine cancer	1.97e-05	0.00101	CbGpPWpGaD
Teniposide—Urticaria—Epirubicin—uterine cancer	1.97e-05	0.000824	CcSEcCtD
Teniposide—NCOA3—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.96e-05	0.001	CbGpPWpGaD
Teniposide—Body temperature increased—Epirubicin—uterine cancer	1.96e-05	0.00082	CcSEcCtD
Teniposide—Abdominal pain—Epirubicin—uterine cancer	1.96e-05	0.00082	CcSEcCtD
Teniposide—CYP3A5—Biological oxidations—CYP11A1—uterine cancer	1.9e-05	0.000975	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—RRM2—uterine cancer	1.9e-05	0.000973	CbGpPWpGaD
Teniposide—Feeling abnormal—Doxorubicin—uterine cancer	1.89e-05	0.000791	CcSEcCtD
Teniposide—CYP3A5—Metapathway biotransformation—CYP11A1—uterine cancer	1.88e-05	0.000962	CbGpPWpGaD
Teniposide—Gastrointestinal pain—Doxorubicin—uterine cancer	1.87e-05	0.000785	CcSEcCtD
Teniposide—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	1.87e-05	0.000958	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—RRM2—uterine cancer	1.86e-05	0.000953	CbGpPWpGaD
Teniposide—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.86e-05	0.000952	CbGpPWpGaD
Teniposide—NCOA3—EGF/EGFR Signaling Pathway—AKT1—uterine cancer	1.85e-05	0.000948	CbGpPWpGaD
Teniposide—NCOA1—Generic Transcription Pathway—ESR1—uterine cancer	1.85e-05	0.000947	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—POLD1—uterine cancer	1.85e-05	0.000946	CbGpPWpGaD
Teniposide—Hypersensitivity—Epirubicin—uterine cancer	1.82e-05	0.000765	CcSEcCtD
Teniposide—Urticaria—Doxorubicin—uterine cancer	1.82e-05	0.000763	CcSEcCtD
Teniposide—Abdominal pain—Doxorubicin—uterine cancer	1.81e-05	0.000759	CcSEcCtD
Teniposide—Body temperature increased—Doxorubicin—uterine cancer	1.81e-05	0.000759	CcSEcCtD
Teniposide—NCOA3—Metabolism—DCN—uterine cancer	1.81e-05	0.000926	CbGpPWpGaD
Teniposide—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	1.78e-05	0.000912	CbGpPWpGaD
Teniposide—Asthenia—Epirubicin—uterine cancer	1.78e-05	0.000745	CcSEcCtD
Teniposide—CYP3A5—Metapathway biotransformation—AKR1C3—uterine cancer	1.77e-05	0.000909	CbGpPWpGaD
Teniposide—TOP2A—Mitotic G1-G1/S phases—CDKN1B—uterine cancer	1.77e-05	0.000906	CbGpPWpGaD
Teniposide—Pruritus—Epirubicin—uterine cancer	1.75e-05	0.000734	CcSEcCtD
Teniposide—NCOA1—Developmental Biology—MET—uterine cancer	1.75e-05	0.000895	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—AKR1C1—uterine cancer	1.73e-05	0.000885	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—YWHAE—uterine cancer	1.71e-05	0.000874	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—CYP11A1—uterine cancer	1.7e-05	0.000872	CbGpPWpGaD
Teniposide—Diarrhoea—Epirubicin—uterine cancer	1.69e-05	0.00071	CcSEcCtD
Teniposide—Hypersensitivity—Doxorubicin—uterine cancer	1.69e-05	0.000707	CcSEcCtD
Teniposide—TOP2A—Cell Cycle—MLH1—uterine cancer	1.69e-05	0.000864	CbGpPWpGaD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—EP300—uterine cancer	1.68e-05	0.000859	CbGpPWpGaD
Teniposide—TOP2A—Levonorgestrel—Progesterone—uterine cancer	1.68e-05	0.0192	CbGdCrCtD
Teniposide—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	1.67e-05	0.000854	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—PGR—uterine cancer	1.67e-05	0.000854	CbGpPWpGaD
Teniposide—Asthenia—Doxorubicin—uterine cancer	1.64e-05	0.000689	CcSEcCtD
Teniposide—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	1.62e-05	0.000832	CbGpPWpGaD
Teniposide—ABCG2—Transmembrane transport of small molecules—ABCC9—uterine cancer	1.62e-05	0.000831	CbGpPWpGaD
Teniposide—Pruritus—Doxorubicin—uterine cancer	1.62e-05	0.000679	CcSEcCtD
Teniposide—NCOA3—Metabolism—AKR1C3—uterine cancer	1.61e-05	0.000823	CbGpPWpGaD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—VEGFA—uterine cancer	1.59e-05	0.000814	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—EZH2—uterine cancer	1.58e-05	0.000811	CbGpPWpGaD
Teniposide—TOP2A—Retinoblastoma (RB) in Cancer—TP53—uterine cancer	1.58e-05	0.000809	CbGpPWpGaD
Teniposide—Vomiting—Epirubicin—uterine cancer	1.57e-05	0.00066	CcSEcCtD
Teniposide—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	1.57e-05	0.000804	CbGpPWpGaD
Teniposide—Diarrhoea—Doxorubicin—uterine cancer	1.57e-05	0.000657	CcSEcCtD
Teniposide—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	1.56e-05	0.000801	CbGpPWpGaD
Teniposide—Rash—Epirubicin—uterine cancer	1.56e-05	0.000654	CcSEcCtD
Teniposide—Dermatitis—Epirubicin—uterine cancer	1.56e-05	0.000654	CcSEcCtD
Teniposide—Headache—Epirubicin—uterine cancer	1.55e-05	0.00065	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—ERBB2—uterine cancer	1.54e-05	0.000791	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—RRM2—uterine cancer	1.54e-05	0.000789	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—YWHAE—uterine cancer	1.53e-05	0.000781	CbGpPWpGaD
Teniposide—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	1.51e-05	0.000775	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—DCN—uterine cancer	1.49e-05	0.000766	CbGpPWpGaD
Teniposide—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	1.49e-05	0.000765	CbGpPWpGaD
Teniposide—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	1.47e-05	0.000754	CbGpPWpGaD
Teniposide—Nausea—Epirubicin—uterine cancer	1.47e-05	0.000616	CcSEcCtD
Teniposide—NCOA1—Gene Expression—ESR2—uterine cancer	1.47e-05	0.000752	CbGpPWpGaD
Teniposide—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	1.46e-05	0.000748	CbGpPWpGaD
Teniposide—Vomiting—Doxorubicin—uterine cancer	1.46e-05	0.000611	CcSEcCtD
Teniposide—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	1.45e-05	0.000744	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	1.45e-05	0.000741	CbGpPWpGaD
Teniposide—Rash—Doxorubicin—uterine cancer	1.44e-05	0.000605	CcSEcCtD
Teniposide—Dermatitis—Doxorubicin—uterine cancer	1.44e-05	0.000605	CcSEcCtD
Teniposide—Headache—Doxorubicin—uterine cancer	1.44e-05	0.000602	CcSEcCtD
Teniposide—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	1.43e-05	0.00073	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—CYP11A1—uterine cancer	1.41e-05	0.000721	CbGpPWpGaD
Teniposide—CYP3A5—Biological oxidations—CYP19A1—uterine cancer	1.4e-05	0.000718	CbGpPWpGaD
Teniposide—CYP3A5—Metapathway biotransformation—CYP19A1—uterine cancer	1.38e-05	0.000708	CbGpPWpGaD
Teniposide—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	1.37e-05	0.000702	CbGpPWpGaD
Teniposide—Nausea—Doxorubicin—uterine cancer	1.36e-05	0.00057	CcSEcCtD
Teniposide—NCOA3—Developmental Biology—CTNNB1—uterine cancer	1.35e-05	0.000692	CbGpPWpGaD
Teniposide—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	1.34e-05	0.000688	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	1.34e-05	0.000687	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—AKR1C3—uterine cancer	1.33e-05	0.000681	CbGpPWpGaD
Teniposide—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	1.32e-05	0.000678	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	1.31e-05	0.000669	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDKN2B—uterine cancer	1.28e-05	0.000656	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—ERBB2—uterine cancer	1.28e-05	0.000654	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	1.27e-05	0.000649	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—EP300—uterine cancer	1.26e-05	0.000643	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—STK11—uterine cancer	1.25e-05	0.000642	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—CYP19A1—uterine cancer	1.25e-05	0.000642	CbGpPWpGaD
Teniposide—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	1.25e-05	0.00064	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	1.23e-05	0.000632	CbGpPWpGaD
Teniposide—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	1.23e-05	0.000628	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—CDKN2B—uterine cancer	1.19e-05	0.000612	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	1.19e-05	0.00061	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—VEGFA—uterine cancer	1.19e-05	0.000609	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—PTEN—uterine cancer	1.19e-05	0.000607	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	1.18e-05	0.000603	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.18e-05	0.000602	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—NRAS—uterine cancer	1.17e-05	0.000602	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDKN2B—uterine cancer	1.15e-05	0.000587	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—EP300—uterine cancer	1.13e-05	0.000579	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.12e-05	0.000574	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—CTNNB1—uterine cancer	1.12e-05	0.000572	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	1.12e-05	0.000571	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—BIRC5—uterine cancer	1.11e-05	0.000566	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—SMAD3—uterine cancer	1.09e-05	0.000559	CbGpPWpGaD
Teniposide—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	1.08e-05	0.000555	CbGpPWpGaD
Teniposide—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	1.07e-05	0.000549	CbGpPWpGaD
Teniposide—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	1.07e-05	0.000547	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—NDUFB11—uterine cancer	1.05e-05	0.000538	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—SRD5A2—uterine cancer	1.05e-05	0.000538	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—EP300—uterine cancer	1.04e-05	0.000532	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—CYP19A1—uterine cancer	1.04e-05	0.000531	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—STK11—uterine cancer	1.04e-05	0.000531	CbGpPWpGaD
Teniposide—ABCG2—HIF-1-alpha transcription factor network—AKT1—uterine cancer	1.01e-05	0.000519	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—KRAS—uterine cancer	1.01e-05	0.000518	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—BIRC5—uterine cancer	9.89e-06	0.000506	CbGpPWpGaD
Teniposide—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	9.88e-06	0.000506	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—VEGFA—uterine cancer	9.84e-06	0.000504	CbGpPWpGaD
Teniposide—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	9.74e-06	0.000499	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	9.73e-06	0.000498	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—NRAS—uterine cancer	9.72e-06	0.000498	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	9.48e-06	0.000486	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	9.45e-06	0.000484	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	9.45e-06	0.000484	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—MTHFR—uterine cancer	9.41e-06	0.000482	CbGpPWpGaD
Teniposide—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	9.41e-06	0.000482	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—EP300—uterine cancer	9.28e-06	0.000475	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—ESR1—uterine cancer	8.9e-06	0.000456	CbGpPWpGaD
Teniposide—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	8.86e-06	0.000454	CbGpPWpGaD
Teniposide—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	8.73e-06	0.000447	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	8.71e-06	0.000446	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	8.62e-06	0.000441	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	8.62e-06	0.000441	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—HRAS—uterine cancer	8.59e-06	0.00044	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	8.43e-06	0.000432	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—KRAS—uterine cancer	8.36e-06	0.000428	CbGpPWpGaD
Teniposide—NCOA3—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	8.3e-06	0.000425	CbGpPWpGaD
Teniposide—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	8.25e-06	0.000422	CbGpPWpGaD
Teniposide—TOP2A—Circadian rythm related genes—TP53—uterine cancer	8.09e-06	0.000414	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—MTHFR—uterine cancer	7.79e-06	0.000399	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—AKR1B1—uterine cancer	7.6e-06	0.000389	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—STAR—uterine cancer	7.6e-06	0.000389	CbGpPWpGaD
Teniposide—NCOA3—Developmental Biology—AKT1—uterine cancer	7.59e-06	0.000389	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—SRD5A2—uterine cancer	7.53e-06	0.000386	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—NDUFB11—uterine cancer	7.53e-06	0.000386	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDKN2A—uterine cancer	7.33e-06	0.000375	CbGpPWpGaD
Teniposide—TOP2A—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	7.12e-06	0.000364	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—HRAS—uterine cancer	7.11e-06	0.000364	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.94e-06	0.000355	CbGpPWpGaD
Teniposide—NCOA1—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	6.86e-06	0.000351	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDKN2A—uterine cancer	6.55e-06	0.000336	CbGpPWpGaD
Teniposide—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	6.52e-06	0.000334	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—CDKN1B—uterine cancer	6.49e-06	0.000332	CbGpPWpGaD
Teniposide—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	6.43e-06	0.000329	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	6.33e-06	0.000324	CbGpPWpGaD
Teniposide—NCOA1—Developmental Biology—AKT1—uterine cancer	6.28e-06	0.000321	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—POLD1—uterine cancer	5.96e-06	0.000305	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—NDUFB11—uterine cancer	5.82e-06	0.000298	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—SRD5A2—uterine cancer	5.82e-06	0.000298	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—CDKN1B—uterine cancer	5.8e-06	0.000297	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle, Mitotic—EP300—uterine cancer	5.7e-06	0.000292	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.66e-06	0.00029	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—AKR1C1—uterine cancer	5.58e-06	0.000286	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—STAR—uterine cancer	5.44e-06	0.000279	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—AKR1B1—uterine cancer	5.44e-06	0.000279	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	5.34e-06	0.000273	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—SRD5A2—uterine cancer	5.31e-06	0.000272	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—NDUFB11—uterine cancer	5.31e-06	0.000272	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PTEN—uterine cancer	5.24e-06	0.000268	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	5.16e-06	0.000264	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—EP300—uterine cancer	5.1e-06	0.000261	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—EP300—uterine cancer	4.99e-06	0.000256	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—RRM2—uterine cancer	4.97e-06	0.000255	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	4.87e-06	0.000249	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—DCN—uterine cancer	4.83e-06	0.000247	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—CYP11A1—uterine cancer	4.55e-06	0.000233	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PTEN—uterine cancer	4.33e-06	0.000222	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—AKR1C3—uterine cancer	4.29e-06	0.00022	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—POLD1—uterine cancer	4.27e-06	0.000219	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—AKR1B1—uterine cancer	4.21e-06	0.000216	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—STAR—uterine cancer	4.21e-06	0.000216	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	4.16e-06	0.000213	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—EP300—uterine cancer	4.13e-06	0.000212	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—AKR1C1—uterine cancer	4e-06	0.000205	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—STAR—uterine cancer	3.84e-06	0.000197	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—AKR1B1—uterine cancer	3.84e-06	0.000197	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	3.79e-06	0.000194	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—PIK3CA—uterine cancer	3.69e-06	0.000189	CbGpPWpGaD
Teniposide—TOP2A—Cell Cycle—TP53—uterine cancer	3.65e-06	0.000187	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—RRM2—uterine cancer	3.56e-06	0.000182	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—SRD5A2—uterine cancer	3.5e-06	0.000179	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—NDUFB11—uterine cancer	3.5e-06	0.000179	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—DCN—uterine cancer	3.46e-06	0.000177	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—STK11—uterine cancer	3.35e-06	0.000171	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—CYP19A1—uterine cancer	3.35e-06	0.000171	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—POLD1—uterine cancer	3.3e-06	0.000169	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—CYP11A1—uterine cancer	3.26e-06	0.000167	CbGpPWpGaD
Teniposide—NCOA1—Gene Expression—AKT1—uterine cancer	3.21e-06	0.000164	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—AKR1C1—uterine cancer	3.09e-06	0.000158	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—AKR1C3—uterine cancer	3.08e-06	0.000158	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—PIK3CA—uterine cancer	3.06e-06	0.000156	CbGpPWpGaD
Teniposide—NCOA3—Metabolism—AKT1—uterine cancer	3.02e-06	0.000155	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—POLD1—uterine cancer	3.01e-06	0.000154	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—AKR1C1—uterine cancer	2.82e-06	0.000144	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—RRM2—uterine cancer	2.75e-06	0.000141	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—DCN—uterine cancer	2.67e-06	0.000137	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—AKR1B1—uterine cancer	2.53e-06	0.00013	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—STAR—uterine cancer	2.53e-06	0.00013	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—CYP11A1—uterine cancer	2.52e-06	0.000129	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—MTHFR—uterine cancer	2.51e-06	0.000129	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—RRM2—uterine cancer	2.51e-06	0.000129	CbGpPWpGaD
Teniposide—NCOA1—Metabolism—AKT1—uterine cancer	2.5e-06	0.000128	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—DCN—uterine cancer	2.44e-06	0.000125	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—STK11—uterine cancer	2.4e-06	0.000123	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—CYP19A1—uterine cancer	2.4e-06	0.000123	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—AKR1C3—uterine cancer	2.38e-06	0.000122	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—CYP11A1—uterine cancer	2.3e-06	0.000118	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—AKR1C3—uterine cancer	2.17e-06	0.000111	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—POLD1—uterine cancer	1.99e-06	0.000102	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—AKR1C1—uterine cancer	1.86e-06	9.51e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—STK11—uterine cancer	1.85e-06	9.49e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—CYP19A1—uterine cancer	1.85e-06	9.49e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—MTHFR—uterine cancer	1.8e-06	9.22e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.74e-06	8.91e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—STK11—uterine cancer	1.69e-06	8.65e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—CYP19A1—uterine cancer	1.69e-06	8.65e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.66e-06	8.49e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—RRM2—uterine cancer	1.66e-06	8.48e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—DCN—uterine cancer	1.61e-06	8.23e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	1.59e-06	8.12e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—CYP11A1—uterine cancer	1.51e-06	7.76e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	1.51e-06	7.75e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—AKR1C3—uterine cancer	1.43e-06	7.32e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PTEN—uterine cancer	1.4e-06	7.16e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—MTHFR—uterine cancer	1.39e-06	7.13e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—EP300—uterine cancer	1.33e-06	6.83e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—MTHFR—uterine cancer	1.27e-06	6.5e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.23e-06	6.28e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	1.12e-06	5.73e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—STK11—uterine cancer	1.11e-06	5.71e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—CYP19A1—uterine cancer	1.11e-06	5.71e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PTEN—uterine cancer	1e-06	5.13e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—PIK3CA—uterine cancer	9.87e-07	5.05e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—EP300—uterine cancer	9.56e-07	4.89e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—MTHFR—uterine cancer	8.37e-07	4.29e-05	CbGpPWpGaD
Teniposide—ABCG2—Metabolism—AKT1—uterine cancer	8.06e-07	4.13e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PTEN—uterine cancer	7.75e-07	3.97e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—EP300—uterine cancer	7.39e-07	3.78e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—PIK3CA—uterine cancer	7.07e-07	3.62e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PTEN—uterine cancer	7.06e-07	3.62e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—EP300—uterine cancer	6.74e-07	3.45e-05	CbGpPWpGaD
Teniposide—CYP3A5—Metabolism—AKT1—uterine cancer	5.77e-07	2.96e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—PIK3CA—uterine cancer	5.46e-07	2.8e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—PIK3CA—uterine cancer	4.98e-07	2.55e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PTEN—uterine cancer	4.66e-07	2.39e-05	CbGpPWpGaD
Teniposide—CYP2C19—Metabolism—AKT1—uterine cancer	4.46e-07	2.29e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—EP300—uterine cancer	4.44e-07	2.27e-05	CbGpPWpGaD
Teniposide—CYP2C9—Metabolism—AKT1—uterine cancer	4.07e-07	2.08e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—PIK3CA—uterine cancer	3.29e-07	1.68e-05	CbGpPWpGaD
Teniposide—CYP3A4—Metabolism—AKT1—uterine cancer	2.68e-07	1.37e-05	CbGpPWpGaD
